Central blood pressure and pulse wave velocity: Relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Gamez Marcos, Manuel A ^a   Recio Rodríguez, José I ^a   Rodríguez Snchez, Emiliano ^a   Castão Snchez, Yolanda ^a   De Cabo Laso, Angela ^a   Snchez Salgado, Benigna ^a   Rodríguez Martín, Carmela ^a   Castão Snchez, Carmen ^a   Gámez Snchez, Leticia ^a   García Ortiz, Luis ^a  

^a Biomedical Research Institute of Salamanca IBSAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; ECHOGRAPHY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS; VASODILATOR AGENTS;

EID: 84866293547     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-143     Document Type: Article

References (48)

1. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. H King RE Aubert WH Herman, Diabetes Care 1998 21 1414 31 10.2337/diacare.21.9.1414 9727886 (Pubitemid 28405191)
2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 1047 53 10.2337/diacare.27.5.1047 15111519 (Pubitemid 38579764)
3. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. SM Haffner S Lehto T Ronnemaa K Pyorala M Laakso, N Engl J Med 1998 339 229 34 10.1056/NEJM199807233390404 9673301 (Pubitemid 28350165)
4. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. J Stamler O Vaccaro JD Neaton D Wentworth, Diabetes Care 1993 16 434 44 10.2337/diacare.16.2.434 8432214 (Pubitemid 23046633)
5. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). RC Turner H Millns HA Neil IM Stratton SE Manley DR Matthews RR Holman, Bmj 1998 316 823 8 9549452
6. Hypertension and macrovascular disease - the killing fields of NIDDM. M Laakso, Diabetes Res Clin Pract 1998 39 Suppl 27 33 10.1016/S0168-8227(98)00020- 5 9649957
7. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. JR Sowers M Epstein, Hypertension 1995 26 869 79 7490142
8. The Hypertension in Diabetes Study (HDS): a catalyst for change. B Williams, Diabet Med 2008 25 Suppl 2 13 9 10.1111/j.1464-5491.2008.02506.x 18717973
9. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. G Howard DH O'Leary D Zaccaro S Haffner M Rewers R Hamman JV Selby MF Saad P Savage R Bergman, Circulation 1996 93 1809 17 8635260
10. [Treatment of arterial hypertension in the diabetic patient. From theory to hard reality]. B Maceira L Perez Tamajon M Losada, Nefrologia 2001 21 Suppl 3 39 45 11642205
11. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. L Tarnow P Rossing MA Gall FS Nielsen HH Parving, Diabetes Care 1994 17 1247 51 10.2337/diacare.17.11.1247 7821162
12. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. J Tuomilehto D Rastenyte WH Birkenhager L Thijs R Antikainen CJ Bulpitt AE Fletcher F Forette A Goldhaber P Palatini C Sarti R Fagard, N Engl J Med 1999 340 677 84 10.1056/NEJM199903043400902 10053176
13. Influence of diabetes and type of hypertension on response to antihypertensive treatment. MJ Brown A Castaigne PW de Leeuw G Mancia CR Palmer T Rosenthal LM Ruilope, Hypertension 2000 35 1038 42 10818061
14. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JD Curb SL Pressel JA Cutler PJ Savage WB Applegate H Black G Camel BR Davis PH Frost N Gonzalez G Guthrie A Oberman GH Rutan J Stamler, Jama 1996 276 1886 92 10.1001/jama.276.23.1886 8968014
15. [The impact of dipper and non-dipper characteristics in the fluctuation of arterial blood pressure. A study of a population of 484 diabetic patients]. B Bauduceau H Mayaudon O Dupuy M Palou E Czerniak C Bredin G Belmejdoub, Arch Mal Coeur Vaiss 2000 93 969 73 10989739
16. -2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). G Mancia G De Backer A Dominiczak R Cifkova R Fagard G Germano G Grassi AM Heagerty SE Kjeldsen S Laurent K Narkiewicz L Ruilope A Rynkiewicz RE Schmieder HA Boudier A Zanchetti A Vahanian J Camm R De Caterina V Dean K Dickstein G Filippatos C Funck-Brentano I Hellemans SD Kristensen K McGregor U Sechtem S Silber M Tendera P Widimsky JL Zamorano S Erdine W Kiowski E Agabiti-Rosei E Ambrosioni LH Lindholm M Viigimaa S Adamopoulos E Agabiti-Rosei E Ambrosioni V Bertomeu D Clement S Erdine C Farsang D Gaita G Lip JM Mallion AJ Manolis PM Nilsson E O'Brien P Ponikowski J Redon F Ruschitzka J Tamargo P van Zwieten B Waeber B Williams, J Hypertens 2007 25 1105 87 10.1097/HJH.0b013e3281fc975a 17563527
17. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. E Dolan A Stanton L Thijs K Hinedi N Atkins S McClory E Den Hond P McCormack JA Staessen E O'Brien, Hypertension 2005 46 156 61 10.1161/01.HYP.0000170138.56903.7a 15939805
18. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. E O'Brien R Asmar L Beilin Y Imai JM Mallion G Mancia T Mengden M Myers P Padfield P Palatini G Parati T Pickering J Redon J Staessen G Stergiou P Verdecchia, J Hypertens 2003 21 821 48 10.1097/00004872-200305000-00001 12714851
19. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. R Sega R Facchetti M Bombelli G Cesana G Corrao G Grassi G Mancia, Circulation 2005 111 1777 83 10.1161/01.CIR.0000160923.04524.5B 15809377
20. Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study). L Garcia-Ortiz MA Gomez-Marcos J Martin-Moreiras LJ Gonzalez-Elena JI Recio-Rodriguez Y Castano-Sanchez G Grandes C Martinez-Salgado, Blood Press Monit 2009 14 145 51 10.1097/MBP.0b013e32832e062f 19581802
21. Ambulatory blood pressure and mortality: a population-based study. TW Hansen J Jeppesen S Rasmussen H Ibsen C Torp-Pedersen, Hypertension 2005 45 499 504 10.1161/01.HYP.0000160402.39597.3b 15753229
22. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. M Kikuya T Ohkubo K Asayama H Metoki T Obara S Saito J Hashimoto K Totsune H Hoshi H Satoh Y Imai, Hypertension 2005 45 240 5 10.1161/01.HYP.0000152079.04553.2c 15596571
23. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. P Verdecchia C Porcellati G Reboldi R Gattobigio C Borgioni TA Pearson G Ambrosio, Circulation 2001 104 2039 44 10.1161/hc4201.097944 11673343
24. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. NS Anavekar JJ McMurray EJ Velazquez SD Solomon L Kober JL Rouleau HD White R Nordlander A Maggioni K Dickstein S Zelenkofske JD Leimberger RM Califf MA Pfeffer, N Engl J Med 2004 351 1285 95 10.1056/NEJMoa041365 15385655
25. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. HC Gerstein JF Mann Q Yi B Zinman SF Dinneen B Hoogwerf JP Halle J Young A Rashkow C Joyce S Nawaz S Yusuf, JAMA 2001 286 421 6 10.1001/jama.286.4.421 11466120
26. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. FG Fowkes GD Murray I Butcher CL Heald RJ Lee LE Chambless AR Folsom AT Hirsch M Dramaix G deBacker JC Wautrecht M Kornitzer AB Newman M Cushman K Sutton-Tyrrell FG Fowkes AJ Lee JF Price RB d'Agostino JM Murabito PE Norman K Jamrozik JD Curb KH Masaki BL Rodriguez JM Dekker LM Bouter RJ Heine G Nijpels CD Stehouwer L Ferrucci MM McDermott HE Stoffers JD Hooi JA Knottnerus M Ogren B Hedblad JC Witteman MM Breteler MG Hunink A Hofman MH Criqui RD Langer A Fronek WR Hiatt R Hamman HE Resnick J Guralnik MM McDermott, Jama 2008 300 197 208 10.1001/jama.300.2.197 18612117
27. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. S Takiuchi K Kamide Y Miwa M Tomiyama M Yoshii T Matayoshi T Horio Y Kawano, J Hum Hypertens 2004 18 17 23 10.1038/sj.jhh.1001628 14688806
28. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. DH O'Leary JF Polak RA Kronmal TA Manolio GL Burke SK Wolfson Jr, N Engl J Med 1999 340 14 22 10.1056/NEJM199901073400103 9878640
29. Central blood pressure measurements and antihypertensive therapy: a consensus document. E Agabiti-Rosei G Mancia MF O'Rourke MJ Roman ME Safar H Smulyan JG Wang IB Wilkinson B Williams C Vlachopoulos, Hypertension 2007 50 154 60 10.1161/HYPERTENSIONAHA.107.090068 17562972
30. Clinical applications of arterial stiffness; definitions and reference values. MF O'Rourke JA Staessen C Vlachopoulos D Duprez GE Plante, Am J Hypertens 2002 15 426 44 10.1016/S0895-7061(01)02319-6 12022246
31. Aortic pulse wave velocity predicts cardiovascular mortality in middle-aged and elderly Japanese men. N Inoue R Maeda H Kawakami T Shokawa H Yamamoto C Ito H Sasaki, Circ J 2009 73 549 53 10.1253/circj.CJ-08-0492 19179770
32. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. CM McEniery Yasmin B McDonnell M Munnery SM Wallace CV Rowe JR Cockcroft IB Wilkinson, Hypertension 2008 51 1476 82 10.1161/HYPERTENSIONAHA.107.105445 18426997
33. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. B Williams PS Lacy SM Thom K Cruickshank A Stanton D Collier AD Hughes H Thurston M O'Rourke, Circulation 2006 113 1213 25 10.1161/CIRCULATIONAHA.105.606962 16476843
34. [SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria]. J Salas-Salvado MA Rubio M Barbany B Moreno, Med Clin (Barc) 2007 128 184 96 10.1016/S0025-7753(07) 72531-9 17298782
35. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. E O'Brien R Asmar L Beilin Y Imai G Mancia T Mengden M Myers P Padfield P Palatini G Parati T Pickering J Redon J Staessen G Stergiou P Verdecchia, J Hypertens 2005 23 697 701 10.1097/01.hjh.0000163132.84890.c4 15775768
36. [Blood pressure self measurement: Spanish consensus document]. A Coca V Bertomeu A Dalfo E Esmatjes F Guillen L Guerrero JL Llisterri R Marin-Iranzo C Megia L Rodriguez-Manas C Suarez, Nefrologia 2007 27 139 53 17564558
37. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. E O'Brien J Petrie W Littler M de Swiet PL Padfield K O'Malley M Jamieson D Altman M Bland N Atkins, J Hypertens 1990 8 607 19 10.1097/00004872-199007000-00004 2168451
38. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. PJ Touboul MG Hennerici S Meairs H Adams P Amarenco N Bornstein L Csiba M Desvarieux S Ebrahim M Fatar R Hernandez Hernandez M Jaff S Kownator P Prati T Rundek M Sitzer U Schminke JC Tardif A Taylor E Vicaut KS Woo F Zannad M Zureik, Cerebrovasc Dis 2007 23 75 80 10.1159/000097034 17108679
39. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. AT Hirsch ZJ Haskal NR Hertzer CW Bakal MA Creager JL Halperin LF Hiratzka WR Murphy JW Olin JB Puschett KA Rosenfield D Sacks JC Stanley LM Taylor Jr CJ White J White RA White EM Antman SC Smith Jr CD Adams JL Anderson DP Faxon V Fuster RJ Gibbons SA Hunt AK Jacobs R Nishimura JP Ornato RL Page B Riegel, Circulation 2006 113 463 654 10.1161/CIRCULATIONAHA. 106.174526 16549646
40. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. PM Okin MJ Roman RB Devereux P Kligfield, J Am Coll Cardiol 1995 25 417 23 10.1016/0735-1097(94)00371-V 7829796
41. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. EP Havranek DB Froshaug CD Emserman R Hanratty MJ Krantz FA Masoudi LM Dickinson JF Steiner, Am J Med 2008 121 870 5 10.1016/j.amjmed.2008.05.034 18823858
42. A new equation to estimate glomerular filtration rate. AS Levey LA Stevens CH Schmid YL Zhang AF Castro HI Feldman JW Kusek P Eggers F Van Lente T Greene J Coresh, Ann Intern Med 2009 150 604 12 19414839
43. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth, Ann Intern Med 1999 130 461 70 10075613
44. Some different types of essential hypertension: their course and prognosis. NM Keith HP Wagener NW Barker, Am J Med Sci 1974 268 336 45 10.1097/00000441-197412000-00004 4616627
45. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? K Cruickshank L Riste SG Anderson JS Wright G Dunn RG Gosling, Circulation 2002 106 2085 90 10.1161/01.CIR.0000033824.02722.F7 12379578
46. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. M Cecelja P Chowienczyk, Hypertension 2009 54 1328 36 10.1161/HYPERTENSIONAHA.109.137653 19884567
47. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. PS Lacy DG O'Brien AG Stanley MM Dewar PP Swales B Williams, J Hypertens 2004 22 1937 44 10.1097/00004872- 200410000-00016 15361765
48. Ambulatory arterial stiffness index, pulse wave velocity and augmentation index - interchangeable or mutually exclusive measures? P Jerrard-Dunne A Mahmud J Feely, J Hypertens 2008 26 529 34 10.1097/HJH.0b013e3282f35265 18300865